Scientists have discovered that key compounds from cannabis—CBD and THC—show surprisingly strong effects against ovarian cancer cells. Used together, they slow cell growth, reduce colony formation, and may even block the cancer’s ability to spread. Even more promising, the treatment caused minimal harm to healthy cells and appears to work by restoring a disrupted signaling pathway that fuels tumor growth.
CBD and THC together significantly inhibit ovarian cancer cell growth, colony formation, and migration while remaining relatively non-toxic to healthy cells. These early results hint at a powerful new treatment strategy that warrants deeper investigation. Credit: Shutterstock
In the future, medications derived from cannabis may play a role in treating ovarian cancer. A research team examining two natural compounds found in cannabis discovered that both produced notable anti-cancer activity when tested on ovarian cancer cells. Although significant work is still needed before any patient-ready drug can be developed, the early results highlight a promising path toward new therapies for a cancer that is difficult to detect and even more challenging to manage.
“Ovarian cancer remains one of the deadliest gynecological malignancies, characterized by late diagnosis, high recurrence rates, and limited effective treatment options,” said Dr. Siyao Tong of Khon Kaen University, lead author of the article in Frontiers in Pharmacology. “Our goal is to find alternative drugs that can improve efficacy and potentially reduce toxicity, ultimately bringing new hope to patients facing this challenging disease.”
Read the article at ScienceDaily
